NBS-nytt
03.08.2020
MSc Tine Norman Alver at Institute of Clinical Medicine defended the thesis Investigating the role of Microphthalmia-Associated transcription Factor
... M in melanoma development and drug resistance" for the degree of PhD (Philosophiae Doctor) on the 29th June 2020. The work was carried out under the supervision of Sigurd Leinæs Bøe, Oslo University Hospital.
Malignant melanoma is an aggressive cancer, and the prognosis is poor for patients with advanced disease. Currently, melanoma treatment consists of immunotherapy and therap
Gå til medietMalignant melanoma is an aggressive cancer, and the prognosis is poor for patients with advanced disease. Currently, melanoma treatment consists of immunotherapy and therap
